The Pennsylvania Cancer and Regenerative Medicine Research Center (PCARMRC) is part of an international hub-and-spoke model for regenerative medical inquiry, spearheading research and collaborating with similar centers around the world. The interface between cancer, stem cells, and regeneration is at an historic moment. Recent breakthroughs in cancer immune therapy have resulted in new biotechnology companies and value for patient’s lives. New discoveries in regenerative medicine are at a similar discovery tipping point.
Dr. Pestell’s research in cell cycle, prostate cancer, oncology and stem cells is highly cited; he is ranked first in the world by Google scholar citations in cell cycle and prostate cancer, and second in the world for oncology. Pestell is funded by more than $1 million each year in grant support from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), the Breast Cancer Research Foundation, and the Falk Foundation. He is the recipient of numerous national and international awards and recognitions. https://en.wikipedia.org/wiki/Richard_Pestell.
The PCARMRC is affiliated and a subsidiary of the Baruch S Blumberg Institute, a non-profit 501 C3, located at the Pennsylvania Biotechnology Center.
Stuttgart University http://www.centersysbio.uni-stuttgart.de/
The Weizmann Institute of Science http://www.weizmann.ac.il/immunology/Lapidot/
Karolinska Institute http://www.biocenter.helsinki.fi/bi/katajisto/
European Cancer Stem Cell Research Institute https://www.cardiff.ac.uk/cancer-stem-cell